Hypertension in CKD Market Analysis By Drug Class(Diuretics, RAS Blockade, β - Blockers, Calcium Channel Blockers), By Distribution Channel(Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) & Forecast 2023-2032
The global hypertension in CKD market size was valued at USD 210 million in 2021 and is projected to reach around USD 450 million in 2030 exhibiting a CAGR of 10.6% in the forecasted period. The growing dominance of dialysis and diuretic therapies in hypertension patients to decrease blood volume in the kidneys is anticipated to boost the growth of the hypertension in CKD market during the forecasted period. Furthermore, a sturdy pipeline of anti-hypertension drugs in the clinical stage to treat CKD in patients with high blood pressure is estimated to add-on growth in the hypertension in CKD market during the estimated period. Conversely, lack of awareness regarding chronic kidney disease (CKD) can be a restraint in the growth of this market.
https://wemarketresearch.com/r....eports/hypertension-
